Coya Therapeutics: Funding, Investors & Team (Oct 2026)
Coya Therapeutics is a clinical-stage biotechnology organization growing first-in-class and top tier approaches using receptive administrative T cells (Tregs) to target sickness. The organization's restrictive CTreg (cryopreservation for Tregs) framework is the primary in the business to make an 'off the rack' way to deal with Treg cell treatment considering sequential imbuements. Through our licensed TAI (Tregs Against Inflammation) and EAITM (Exosomes Against Inflammation) stages, Coya is centered around the headway of illness altering ways to deal with address the critical neglected clinical requirements of patients with ALS, Parkinson's, Alzheimer's, FTD and immune system sicknesses.
Coya Therapeutics has raised $84.8M across 6 funding rounds on record, the most recent an undisclosed round of $23.0M announced in Oct 2025.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Coya Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Coya Therapeutics Funding Rounds
Coya Therapeutics raised $10.0M in a Series A announced in Feb 2021.
1.3 years later, an undisclosed round of $10.3M was announced in Jun 2022.
1.5 years later, an undisclosed round of $26.5M was announced in Dec 2023.
5 months later, an undisclosed round of $5.0M was announced in May 2024.
5 months later, an undisclosed round of $10.0M was announced in Oct 2024.
1 years later, an undisclosed round of $23.0M was announced in Oct 2025.
Coya Therapeutics Founders and Leadership Team
Contact details for the Coya Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Coya Therapeutics Funding Compared to Other Biotechnology Startups
Coya Therapeutics' latest round of $23.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Coya Therapeutics in Biotechnology and Houston
Companies Similar to Coya Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Coya Therapeutics Funding FAQs
What does Coya Therapeutics do?
Coya Therapeutics is a clinical-stage biotechnology organization growing first-in-class and top tier approaches using receptive administrative T cells (Tregs) to target sickness. The organization's restrictive CTreg (cryopreservation for Tregs) framework is the primary in the business to make an 'off the rack' way to deal with Treg cell treatment considering sequential imbuements. Through our licensed TAI (Tregs Against Inflammation) and EAITM (Exosomes Against Inflammation) stages, Coya is centered around the headway of illness altering ways to deal with address the critical neglected clinical requirements of patients with ALS, Parkinson's, Alzheimer's, FTD and immune system sicknesses.
How much funding has Coya Therapeutics raised?
Coya Therapeutics has raised $84.8M across 6 rounds on record. The most recent is an undisclosed round of $23.0M announced in Oct 2025.
When did Coya Therapeutics last raise funding?
Coya Therapeutics' most recent funding round on record is an undisclosed round of $23.0M, announced in Oct 2025.
Who is the CEO of Coya Therapeutics?
Howard Berman is listed as CEO at Coya Therapeutics.
Where is Coya Therapeutics headquartered?
Coya Therapeutics is based in Houston, Texas, United States.
How many employees does Coya Therapeutics have?
Coya Therapeutics is in the 1-10 employee band.
How does Coya Therapeutics' funding compare to other Biotechnology startups?
Coya Therapeutics' latest round of $23.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Coya Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Coya Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.